APIS Labor GmbH
PolandAll drugs from this manufacturer
-
The medicine is used in adult patients for the treatment of high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. These are diseases that affect the bone marrow.
Dosage form: powder for preparation of injection suspension
Active substance Dosage azacitidine 25 mg/ml ATC: L01BC07
-
The medicine is used to treat cancer of the colon, rectum, stomach, or breast. It is also used to prevent the recurrence of colon cancer after surgical removal.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 150 mg ATC: L01BC06
-
The medicine is used to treat cancer of the colon, rectum, stomach, or breast. It may also be used to prevent the recurrence of colon cancer after its complete surgical removal.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 500 mg ATC: L01BC06
-
The medicinal product is used to treat malignant tumors, such as mesothelioma (in patients who have not previously undergone chemotherapy) and in the treatment of advanced lung cancer.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage pemetrexed disodium heptahydrate 100 mg ATC: L01BA04
-
The medicinal product is used in the treatment of malignant tumors, such as mesothelioma (in patients who have not previously undergone chemotherapy) and in the treatment of advanced lung cancer.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage pemetrexed 500 mg ATC: L01BA04